No Longer Accepting Cases

Pfizer, the manufacturer of Neurontin, has paid nearly $1 billion to resolve civil and criminal allegations involving illegal “off-label” marketing. This “Pregnancy Category C” drug is not approved during pregnancy. Women who had a baby with a birth defect are now coming forward to seek justice.

Neurontin Class Action Lawsuit Settlements

Nearly $1 billion has been paid to resolve class actions and investigations by the Justice Department involving illegal marketing of Neurontin.

  • June 2014 — Pfizer and its Warner-Lambert Co. subsidiary agreed to pay a $325 million settlement to resolve a decade-long class action lawsuit accusing the drug-makers of boosting profits by promoting Neurontin for uses that were not FDA-approved or clinically effective.
  • April 2014 — Pfizer agreed to pay a $190 million settlement to resolve a separate class action on behalf of people who purchased Neurontin. The lawsuit accusing the drug-maker of inflating prices by taking aggressive steps to keep cheaper generic versions of the drug off the market.
  • May 2004 — The Justice Department announced that Pfizer agreed to pay $430 million to settle civil and criminal allegations that Neurontin was illegally promoted “off-label” for unapproved purposes, including migraine headaches, bipolar disorder, attention deficit, and more.

Birth Defects Linked to Neurontin

  • Cleft lip
  • Cleft palate
  • Heart defects
  • Spina bifida
  • Limb reduction defects
  • Gastrointestinal defects
  • Reproductive system defects (hypospadia)
  • And more

About Class Actions

When a large number of people need reimbursement for a defective product, class actions make a lot of sense. However, they can also have disadvantages — especially for people with very serious injuries. Members may have to accept high attorneys’ fees, a “low-ball settlement,” and never see their case taken to trial.

Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Neurontin Class Action

When medications can potentially cause birth defects, drug-makers are responsible for explicitly warning pregnant women against taking that medication. Drug-makers who continue to promote a dangerous drug for “off-label” uses while failing to warn about birth defects can be held liable for negligence.

 

Leave a reply

Your email address will not be published. Required fields are marked *

About Collen

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen A. Clark
“Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 879-3040.
*
*
*

Related Content on Our Website